Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 4/2013

01.04.2013 | Original Paper

Left atrial appendage: morphology and function in patients with paroxysmal and persistent atrial fibrillation

verfasst von: Hwan-Cheol Park, Jinho Shin, Ji-Eun Ban, Jong-Il Choi, Sang-Weon Park, Young-Hoon Kim

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

The anatomical and functional characteristics of the left atrial appendage (LAA) and its relationships with anatomical remodeling and ischemic stroke in patients with atrial fibrillation (AF) have not been clearly established. The purpose of this study was to determine whether functional and morphological features of the LAA independently predict clinical outcome and stroke in patients with AF who underwent catheter ablation (CA). Two hundred sixty-four patients with AF, including 176 with paroxysmal AF (PAF, 54.0 ± 11.4 years old, M:F = 138:38) and 88 with persistent AF (PeAF, 56.4 ± 9.6 years old, M:F = 74:14) were studied. Of these patients, 31 (11.7 %) had a history of stroke/TIA (transient ischemic attack). The LA and LAA volumes were 124.0 ± 42.4 and 24.9 ± 4.3 ml in PeAF, these values were greater than those in PAF (81.2 ± 24.8 ml and 21.2 ± 5.1 ml, P < 0.001). The AF type (P = 0.016) and AF duration (P = 0.005), and anti-arrhythmic drugs use (P < 0.001) were significant predictors of AF recurrence after CA in all patients. Compared with patients without history of stroke, stroke patients had larger LA volume (106.9 ± 23.0 vs. 94.0 ± 38.9 ml, P = 0.004) and had lower LAA EF (50.0 ± 11.0 vs. 65.7 ± 13.4 %, P < 0.001). The independent predictors of stroke were age (P = 0.002) and LAA EF (P < 0.001) in PAF patients and that was only age (P = 0.001) in PeAF patients. In anatomical and morphological parameters of the LA and LAA, only depressed systolic function of the LAA was significantly related to stroke/TIA and recurrence of AF after CA in paroxysmal AF patients. Further large scaled prospective study is required for validation.
Literatur
1.
2.
Zurück zum Zitat Chang SH, Tsao HM, Wu MH et al (2007) Morphological changes of the left atrial appendage after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 18(1):47–52PubMedCrossRef Chang SH, Tsao HM, Wu MH et al (2007) Morphological changes of the left atrial appendage after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 18(1):47–52PubMedCrossRef
3.
Zurück zum Zitat Corradi D, Callegari S, Benussi S et al (2005) Myocyte changes and their left atrial distribution in patients with chronic atrial fibrillation related to mitral valve disease. Hum Pathol 36(10):1080–1089PubMedCrossRef Corradi D, Callegari S, Benussi S et al (2005) Myocyte changes and their left atrial distribution in patients with chronic atrial fibrillation related to mitral valve disease. Hum Pathol 36(10):1080–1089PubMedCrossRef
4.
Zurück zum Zitat Daoud EG, Weiss R, Bahu M et al (1996) Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 78(12):1433–1436PubMedCrossRef Daoud EG, Weiss R, Bahu M et al (1996) Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 78(12):1433–1436PubMedCrossRef
5.
Zurück zum Zitat Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM (1997) Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 29(4):709–715PubMedCrossRef Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM (1997) Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 29(4):709–715PubMedCrossRef
6.
Zurück zum Zitat Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988PubMedCrossRef Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988PubMedCrossRef
7.
Zurück zum Zitat Fuster V, Ryden LE, Cannom DS et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(7):e257–e354PubMedCrossRef Fuster V, Ryden LE, Cannom DS et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(7):e257–e354PubMedCrossRef
8.
Zurück zum Zitat Lo LW, Tai CT, Lin YJ et al (2009) Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: implications for catheter ablation strategy and long-term outcome. Heart Rhythm 6(3):311–318PubMedCrossRef Lo LW, Tai CT, Lin YJ et al (2009) Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: implications for catheter ablation strategy and long-term outcome. Heart Rhythm 6(3):311–318PubMedCrossRef
9.
Zurück zum Zitat Berruezo A, Tamborero D, Mont L et al (2007) Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 28(7):836–841PubMedCrossRef Berruezo A, Tamborero D, Mont L et al (2007) Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 28(7):836–841PubMedCrossRef
10.
Zurück zum Zitat Qamruddin S, Shinbane J, Shriki J, Naqvi TZ (2010) Left atrial appendage: structure, function, imaging modalities and therapeutic options. Expert Rev Cardiovasc Ther 8(1):65–75PubMedCrossRef Qamruddin S, Shinbane J, Shriki J, Naqvi TZ (2010) Left atrial appendage: structure, function, imaging modalities and therapeutic options. Expert Rev Cardiovasc Ther 8(1):65–75PubMedCrossRef
11.
Zurück zum Zitat Calkins H, Brugada J, Packer DL et al (2007) HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 4(6):816–861PubMedCrossRef Calkins H, Brugada J, Packer DL et al (2007) HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 4(6):816–861PubMedCrossRef
12.
Zurück zum Zitat Natale A, Raviele A, Arentz T et al (2007) Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 18(5):560–580PubMedCrossRef Natale A, Raviele A, Arentz T et al (2007) Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 18(5):560–580PubMedCrossRef
13.
Zurück zum Zitat Pollak A, Falk RH (1995) Aggravation of postcardioversion atrial dysfunction by sotalol. J Am Coll Cardiol 25(3):665–671PubMedCrossRef Pollak A, Falk RH (1995) Aggravation of postcardioversion atrial dysfunction by sotalol. J Am Coll Cardiol 25(3):665–671PubMedCrossRef
14.
Zurück zum Zitat Wang Y, Di Biase L, Horton RP, Nguyen T, Morhanty P, Natale A (2010) Left atrial appendage studied by computed tomography to help planning for appendage closure device placement. J Cardiovasc Electrophysiol 21(9):973–982PubMedCrossRef Wang Y, Di Biase L, Horton RP, Nguyen T, Morhanty P, Natale A (2010) Left atrial appendage studied by computed tomography to help planning for appendage closure device placement. J Cardiovasc Electrophysiol 21(9):973–982PubMedCrossRef
15.
Zurück zum Zitat Beinart R, Heist EK, Newell JB, Holmvang G, Ruskin JN, Mansour M (2011) Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation. J Cardiovasc Electrophysiol 22(1):10–15PubMedCrossRef Beinart R, Heist EK, Newell JB, Holmvang G, Ruskin JN, Mansour M (2011) Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation. J Cardiovasc Electrophysiol 22(1):10–15PubMedCrossRef
16.
Zurück zum Zitat Pollick C, Taylor D (1991) Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus. Circulation 84(1):223–231PubMedCrossRef Pollick C, Taylor D (1991) Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus. Circulation 84(1):223–231PubMedCrossRef
17.
Zurück zum Zitat Sahin T, Ural D, Kilic T et al (2009) Evaluation of left atrial appendage functions according to different etiologies of atrial fibrillation with a tissue Doppler imaging technique by using transesophageal echocardiography. Echocardiography 26(2):171–181PubMedCrossRef Sahin T, Ural D, Kilic T et al (2009) Evaluation of left atrial appendage functions according to different etiologies of atrial fibrillation with a tissue Doppler imaging technique by using transesophageal echocardiography. Echocardiography 26(2):171–181PubMedCrossRef
18.
Zurück zum Zitat Fleming HA, Bailey SM (1971) Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J 47(551):599–604PubMedCrossRef Fleming HA, Bailey SM (1971) Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J 47(551):599–604PubMedCrossRef
19.
Zurück zum Zitat Neilson GH, Galea EG, Hossack KF (1978) Thromboembolic complications of mitral valve disease. Aust N Z J Med 8(4):372–376PubMedCrossRef Neilson GH, Galea EG, Hossack KF (1978) Thromboembolic complications of mitral valve disease. Aust N Z J Med 8(4):372–376PubMedCrossRef
20.
Zurück zum Zitat Al-Saady NM, Obel OA, Camm AJ (1999) Left atrial appendage: structure, function, and role in thromboembolism. Heart 82(5):547–554PubMed Al-Saady NM, Obel OA, Camm AJ (1999) Left atrial appendage: structure, function, and role in thromboembolism. Heart 82(5):547–554PubMed
21.
Zurück zum Zitat Kamp O, Verhorst PM, Welling RC, Visser CA (1999) Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation. Eur Heart J 20(13):979–985PubMedCrossRef Kamp O, Verhorst PM, Welling RC, Visser CA (1999) Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation. Eur Heart J 20(13):979–985PubMedCrossRef
22.
Zurück zum Zitat Choudhury A, Lip GY (2003) Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice. Pathophysiol Haemost Thromb 33(5–6):282–289PubMedCrossRef Choudhury A, Lip GY (2003) Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice. Pathophysiol Haemost Thromb 33(5–6):282–289PubMedCrossRef
23.
Zurück zum Zitat Heppell RM, Berkin KE, McLenachan JM, Davies JA (1997) Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 77(5):407–411PubMed Heppell RM, Berkin KE, McLenachan JM, Davies JA (1997) Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 77(5):407–411PubMed
24.
Zurück zum Zitat Leithauser B, Park JW (2009) Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage. Korean Circ J 39(11):443–458PubMedCrossRef Leithauser B, Park JW (2009) Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage. Korean Circ J 39(11):443–458PubMedCrossRef
25.
Zurück zum Zitat Ernst G, Stollberger C, Abzieher F et al (1995) Morphology of the left atrial appendage. Anat Rec 242(4):553–561PubMedCrossRef Ernst G, Stollberger C, Abzieher F et al (1995) Morphology of the left atrial appendage. Anat Rec 242(4):553–561PubMedCrossRef
26.
Zurück zum Zitat Shirani J, Alaeddini J (2000) Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: implications for thrombus formation, systemic embolism, and assessment by transesophageal echocardiography. Cardiovasc Pathol 9(2):95–101PubMedCrossRef Shirani J, Alaeddini J (2000) Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: implications for thrombus formation, systemic embolism, and assessment by transesophageal echocardiography. Cardiovasc Pathol 9(2):95–101PubMedCrossRef
27.
Zurück zum Zitat Parikh SS, Jons C, McNitt S, Daubert JP, Schwarz KQ, Hall B (2010) Predictive capability of left atrial size measured by CT, TEE, and TTE for recurrence of atrial fibrillation following radiofrequency catheter ablation. Pacing Clin Electrophysiol 33(5):532–540PubMedCrossRef Parikh SS, Jons C, McNitt S, Daubert JP, Schwarz KQ, Hall B (2010) Predictive capability of left atrial size measured by CT, TEE, and TTE for recurrence of atrial fibrillation following radiofrequency catheter ablation. Pacing Clin Electrophysiol 33(5):532–540PubMedCrossRef
28.
Zurück zum Zitat von Bary C, Dornia C, Eissnert C et al (2012) Predictive value of left atrial volume measured by non-invasive cardiac imaging in the treatment of paroxysmal atrial fibrillation. J Interv Card Electrophysiol 34(2):181–188CrossRef von Bary C, Dornia C, Eissnert C et al (2012) Predictive value of left atrial volume measured by non-invasive cardiac imaging in the treatment of paroxysmal atrial fibrillation. J Interv Card Electrophysiol 34(2):181–188CrossRef
29.
Zurück zum Zitat (2007) Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 69(6):546–554 (2007) Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 69(6):546–554
30.
Zurück zum Zitat (1996) Silent brain infarction in nonrheumatic atrial fibrillation. EAFT Study Group. European atrial fibrillation trial. Neurology 46(1):159–165 (1996) Silent brain infarction in nonrheumatic atrial fibrillation. EAFT Study Group. European atrial fibrillation trial. Neurology 46(1):159–165
31.
Zurück zum Zitat Das RR, Seshadri S, Beiser AS et al (2008) Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke 39(11):2929–2935PubMedCrossRef Das RR, Seshadri S, Beiser AS et al (2008) Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke 39(11):2929–2935PubMedCrossRef
Metadaten
Titel
Left atrial appendage: morphology and function in patients with paroxysmal and persistent atrial fibrillation
verfasst von
Hwan-Cheol Park
Jinho Shin
Ji-Eun Ban
Jong-Il Choi
Sang-Weon Park
Young-Hoon Kim
Publikationsdatum
01.04.2013
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 4/2013
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-012-0161-y

Weitere Artikel der Ausgabe 4/2013

The International Journal of Cardiovascular Imaging 4/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.